Loading...
The Ensign Group, Inc.
ENSG•NASDAQ
Healthcare
Medical - Care Facilities
$150.06
$12.29(8.92%)
The Ensign Group, Inc. (ENSG) Financial Performance & Income Statement Overview
Review The Ensign Group, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
14.24%
↑ 14.24%
Operating Income Growth
40.31%
↑ 40.31%
Net Income Growth
42.30%
↑ 42.30%
Operating Cash Flow Growth
-7.83%
↓ 7.83%
Operating Margin
8.57%
↑ 8.57%
Gross Margin
17.12%
↑ 17.12%
Net Profit Margin
6.99%
↑ 6.99%
ROE
17.15%
↑ 17.15%
ROIC
9.47%
↑ 9.47%
The Ensign Group, Inc. (ENSG) Income Statement & Financial Overview
Review The Ensign Group, Inc.'s (ENSG) income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $1.17B | $1.13B | $1.08B | $1.04B |
Cost of Revenue | $984.92M | $953.35M | $914.78M | $894.12M |
Gross Profit | $188.12M | $178.91M | $166.99M | $142.16M |
Gross Profit Ratio | $0.16 | $0.16 | $0.15 | $0.14 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $62.55M | $55.61M | $56.18M | $56.03M |
Operating Expenses | $86.74M | $78.13M | $77.65M | $56.03M |
Total Costs & Expenses | $990.40M | $1.03B | $992.20M | $950.15M |
Interest Income | $6.88M | $7.60M | $7.61M | $7.08M |
Interest Expense | $2.04M | $2.26M | $2.02M | $2.04M |
Depreciation & Amortization | $24.19M | $22.52M | $21.47M | $20.49M |
EBITDA | $128.66M | $130.53M | $122.17M | $114.59M |
EBITDA Ratio | $0.11 | $0.12 | $0.11 | $0.11 |
Operating Income | $101.37M | $100.78M | $89.34M | $86.14M |
Operating Income Ratio | $0.09 | $0.09 | $0.08 | $0.08 |
Other Income/Expenses (Net) | $5.21M | $4.98M | $9.34M | $6.09M |
Income Before Tax | $106.58M | $105.76M | $98.67M | $92.06M |
Income Before Tax Ratio | $0.09 | $0.09 | $0.09 | $0.09 |
Income Tax Expense | $26.23M | $26.008M | $20.11M | $20.88M |
Net Income | $80.28M | $79.69M | $78.44M | $71.007M |
Net Income Ratio | $0.07 | $0.07 | $0.07 | $0.07 |
EPS | $1.41 | $1.40 | $1.38 | $1.26 |
Diluted EPS | $1.37 | $1.36 | $1.34 | $1.22 |
Weighted Avg Shares Outstanding | $57.10M | $56.96M | $56.78M | $56.54M |
Weighted Avg Shares Outstanding (Diluted) | $58.50M | $58.58M | $58.44M | $58.01M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan